ENDOCYTE INC·4

Feb 11, 6:11 PM ET

SANDERLING VENTURES MANAGEMENT V 4

4 · ENDOCYTE INC · Filed Feb 11, 2011

Insider Transaction Report

Form 4
Period: 2011-02-09
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2011-02-093,6950 total(indirect: By Sanderling Ventures Management V)
    Common Stock (3,695 underlying)
  • Conversion

    Series C-1 Convertible Preferred Stock

    2011-02-093,6950 total(indirect: By Sanderling Ventures Management V)
    Common Stock (3,695 underlying)
  • Conversion

    Series C-2 Convertible Preferred Stock

    2011-02-094,9270 total(indirect: By Sanderling Ventures Management V)
    Common Stock (4,927 underlying)
  • Conversion

    Series C-3 Convertible Preferred Stock

    2011-02-095,0010 total(indirect: By Sanderling Ventures Management V)
    Common Stock (5,001 underlying)
  • Conversion

    Common Stock

    2011-02-09+17,318149,003 total(indirect: By Sanderling Ventures Management V)
  • Conversion

    Common Stock

    2011-02-09+30,76630,766 total(indirect: By Sanderling Ventures Management VI)
  • Conversion

    Series C-3 Convertible Preferred Stock

    2011-02-0930,7660 total(indirect: By Sanderling Ventures Management VI)
    Common Stock (30,766 underlying)
Footnotes (4)
  • [F1]Each share of the Issuer's Series A-1, Series A-2, Series B, Series C-1, Series C-2 and Series C-3 Preferred Stock automatically converted into shares of Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.
  • [F2]44,502 shares held by Sanderling Ventures Management V are subject to repurchase based on milestones set forth in the Restricted Stock Purchase Agreement dated July 10, 2001 between the Company and each of Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., ABV Holding Company 7 LLC, Douglas G. Bailey, and Cincinnati Financial Corporation.
  • [F3]Mr. Middleton disclaims beneficial ownership of the shares directly held by the entities affiliated with Sanderling except to the extent of his individual pecuniary interest therein.
  • [F4]Fred Middleton is the owner of Sanderling Ventures Management V and Sanderling Ventures Management VI Partnership and he may be deemed to have voting and investment power over shares held of record by Sanderling Ventures Management V and Sanderling Ventures Management VI Partnership.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION